Clinical Trials Logo

Clinical Trial Summary

To examine the efficacy of continued administration of rebamipide following bacteria eradication therapy in patients with H. pylori-positive active gastric ulcer in a placebo-controlled, double-blind study


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00233389
Study type Interventional
Source Otsuka Pharmaceutical Co., Ltd.
Contact
Status Completed
Phase Phase 4
Start date April 30, 2004
Completion date September 9, 2005

See also
  Status Clinical Trial Phase
Completed NCT02299687 - Influence of CYP2C19 Polymorphism on PK/PD of Omeprazole Phase 1
Completed NCT00284908 - Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers Phase 1
Completed NCT00239551 - Effect of Prevacid on Prostaglandin Levels in Patient With Stress Ulcer Phase 4
Completed NCT02710994 - Pharmacodynamics and Safety of CDFR0209 Phase 1
Completed NCT01167101 - Is Rebamipide Effective on the Healing of Iatrogenic Gastric Ulcer After Endoscopic Mucosal Resection? N/A
Terminated NCT00762359 - A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers Phase 3
Completed NCT01376414 - H. Pylori Testing for Patients With Non-specific Upper Abdominal Pain in the Emergency Department N/A
Completed NCT00543868 - MK0782 + Low-Dose Aspirin 7-Day Erosion Endoscopy Study (0782-001) Phase 2
Completed NCT05208268 - A Study of Pariet to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin in Korean Participants With a History of Gastric and Duodenal Ulcer
Completed NCT02032030 - Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes Surveys
Completed NCT00272467 - Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication Therapy Phase 4
Completed NCT03060746 - Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Completed NCT03060733 - Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Completed NCT00125736 - A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium Phase 4
Terminated NCT00839488 - Comparison of Intravenous Pantoprazole and Famotidine for Stress Ulcer Prophylaxis Phase 4
Completed NCT00787254 - Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory Drugs Phase 3
Completed NCT00190255 - Pharmacogenetics of Gastrointestinal Bleeding Phase 4